Akiram Therapeutics

Developer of radiopharmaceuticals for cancer treatment

placeUppsala, Uppsala County, Sweden calendar_todayFounded 2022 groups8 employees language akiramtherapeutics.se

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace accelerating. Cited 14 times.

YearFilings
20231
20241
20251

Social engagement

Social engagement: 1.4K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Sciety, Linc.

Investor typeCountShare
Venture capital250%
Angel & family office125%
Other / undisclosed125%

Recent activity

18 Jun 2026
Event
Almedalen seminar on shortening path from research to patient benefit
17 Jun 2026
Event
Almedalen
13 May 2026
Milestone
regulatory
Coming soon